Orchid Pharma Limited
Disclosure under Regulation 25 and 46 of SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015
Background
Regulation 25(7) of SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 ("SEBI LODR"), requires listed companies to conduct familiarization programme for the Independent Directors so as to familiarize them with the company, their roles, rights, responsibilities in the company, nature of the industry in which the company operates, business model of the company, etc. Further, listed companies are required to disseminate information about the details of familiarization programmes imparted to Independent Directors on its website, as prescribed under Regulation 46 (2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations,2015.
The Company has an on-going familiarisation programme for its Independent Directors.
Details of familiarization programmes imparted to independent directors during the financial year 2020-21:
The Company has an orientation process/familiarization programme for its Independent Directors that includes:
a. Briefing on their role, responsibilities, duties, and obligations as a member of the Board.
b. Nature of business and business model of the Company, Company's strategic and operating plans.
Details of the above Familiarisation programme imparted to Independent Directors during the financial year 2020-2021
Name of the Independent | During the Financial year 2020-2021 | |
Director | Number of familiarisation | Total number of hours |
programmes attended | spent | |
Dr Dharam Vir | 2 | 2 |
Shri Manoj Kumar Goyal | 2 | 2 |
Shri Mudit Tandon | 2 | 2 |
Smt Tanu Singla | 2 | 2 |
***************************************************************************
Attachments
- Original document
- Permalink
Disclaimer
Orchid Pharma Ltd. published this content on 12 April 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 12 April 2021 05:34:06 UTC.